Leah Johnson1, Ryan Karau2, Corey McGee3. 1. University of Minnesota Rehabilitation Science Graduate Program, Minneapolis, MN, USA. Electronic address: joh14258@umn.edu. 2. University of Minnesota Program in Occupational Therapy, Minneapolis, MN, USA. 3. University of Minnesota Rehabilitation Science Graduate Program, Minneapolis, MN, USA; University of Minnesota Program in Occupational Therapy, Minneapolis, MN, USA.
Abstract
STUDY DESIGN: A descriptive psychometric study of precision and concurrent validity of the Thumb Disability Examination (TDX). INTRODUCTION: Thumb carpometacarpal osteoarthritis (CMC OA) is a painful joint condition impacting the functionality of the hand. Therapists use patient-reported outcome measures to evaluate change in disability and symptomology in response to interventions. The TDX is the only condition-specific outcome measure for persons with thumb CMC OA. Its responsiveness, test-retest reliability and concurrent validity with the DASH are published, yet it's precision and concurrent validity with a hand-region-specific tool has not yet been established. PURPOSE OF THE STUDY: We aimed to determine the precision and concurrent validity of the TDX with a region-specific outcome measure in people with thumb CMC OA. METHODS: Sixteen individuals with a medical diagnosis of CMC OA or a positive pressure-shear test completed the TDX across two visits and the Brief Michigan Hand Questionnaire (bMHQ) at the initial visit. The second visit was 7 to 21 days after the first. Self-administration of the TDX and bMHQ were observed by a licensed occupational therapist. RESULTS: Across total and subscale scores of the TDX, standard error of measurement (SEM) values are used to indicate the precision of tool and demonstrate how confident a user can be that change in score exceeds the error inherent to the tool. Minimal detectable change percentage (MDC%) values for the TDX are acceptable (<30%). The TDX demonstrated high concurrent validity with the bMHQ (rs = -0.733; P = .001). DISCUSSION: Precision of the TDX is acceptable and the concurrent validity of the TDX with a commonly used region-specific scale is high. The study was limited by a small, demographically homogeneous sample due to difficulty in recruitment. CONCLUSIONS: The TDX is a precise and valid outcome measure for individuals having a clinical diagnosis or indications of having thumb CMC OA.
STUDY DESIGN: A descriptive psychometric study of precision and concurrent validity of the Thumb Disability Examination (TDX). INTRODUCTION: Thumb carpometacarpal osteoarthritis (CMC OA) is a painful joint condition impacting the functionality of the hand. Therapists use patient-reported outcome measures to evaluate change in disability and symptomology in response to interventions. The TDX is the only condition-specific outcome measure for persons with thumb CMC OA. Its responsiveness, test-retest reliability and concurrent validity with the DASH are published, yet it's precision and concurrent validity with a hand-region-specific tool has not yet been established. PURPOSE OF THE STUDY: We aimed to determine the precision and concurrent validity of the TDX with a region-specific outcome measure in people with thumb CMC OA. METHODS: Sixteen individuals with a medical diagnosis of CMC OA or a positive pressure-shear test completed the TDX across two visits and the Brief Michigan Hand Questionnaire (bMHQ) at the initial visit. The second visit was 7 to 21 days after the first. Self-administration of the TDX and bMHQ were observed by a licensed occupational therapist. RESULTS: Across total and subscale scores of the TDX, standard error of measurement (SEM) values are used to indicate the precision of tool and demonstrate how confident a user can be that change in score exceeds the error inherent to the tool. Minimal detectable change percentage (MDC%) values for the TDX are acceptable (<30%). The TDX demonstrated high concurrent validity with the bMHQ (rs = -0.733; P = .001). DISCUSSION: Precision of the TDX is acceptable and the concurrent validity of the TDX with a commonly used region-specific scale is high. The study was limited by a small, demographically homogeneous sample due to difficulty in recruitment. CONCLUSIONS: The TDX is a precise and valid outcome measure for individuals having a clinical diagnosis or indications of having thumb CMC OA.
Authors: Peter C Noback; Joseph M Lombardi; Mani Seetharaman; Donald H Lee; Robert J Strauch; Melvin P Rosenwasser Journal: J Wrist Surg Date: 2016-10-14
Authors: F P B Kroon; A Boersma; A Boonen; S van Beest; W Damman; D van der Heijde; F R Rosendaal; M Kloppenburg Journal: Osteoarthritis Cartilage Date: 2018-08-09 Impact factor: 6.576
Authors: Martina Wehrli; Stefanie Hensler; Stephan Schindele; Daniel B Herren; Miriam Marks Journal: J Hand Surg Am Date: 2016-07-26 Impact factor: 2.230
Authors: Pavlos Bobos; Joy C MacDermid; Eleni C Boutsikari; Emily A Lalone; Louis Ferreira; Ruby Grewal Journal: Health Qual Life Outcomes Date: 2020-09-09 Impact factor: 3.186